194 related articles for article (PubMed ID: 9311802)
21. Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family.
Sørensen AB; Lund AH; Ethelberg S; Copeland NG; Jenkins NA; Pedersen FS
J Virol; 2000 Mar; 74(5):2161-8. PubMed ID: 10666245
[TBL] [Abstract][Full Text] [Related]
22. Non-identical patterns of proviral insertions around host transcription units in lymphomas induced by different strains of murine leukemia virus.
Martín-Hernández J; Balle Sørensen A; Pedersen FS
Virology; 2006 Sep; 353(1):193-9. PubMed ID: 16790256
[TBL] [Abstract][Full Text] [Related]
23. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
Sun W; Graves BJ; Speck NA
J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
[TBL] [Abstract][Full Text] [Related]
24. Carbon tetrachloride induction of rapid changes in liver nuclear protein factors capable of sequence-specific binding to regulatory elements in the long terminal repeat of polytropic-class endogenous murine leukemia virus-related proviruses.
Hoyt PR; Wang TH; Henley DC; Yang DM; Ch'ang LY; Yang WK
Mol Carcinog; 1993; 8(4):245-54. PubMed ID: 8280373
[TBL] [Abstract][Full Text] [Related]
25. Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus.
Thomas CY; Nuckols JD; Murphy C; Innes D
Virology; 1993 Apr; 193(2):1013-7. PubMed ID: 8384741
[TBL] [Abstract][Full Text] [Related]
26. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element.
Boral AL; Okenquist SA; Lenz J
J Virol; 1989 Jan; 63(1):76-84. PubMed ID: 2535754
[TBL] [Abstract][Full Text] [Related]
27. Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.
Granger SW; Bundy LM; Fan H
J Virol; 1999 Sep; 73(9):7175-84. PubMed ID: 10438804
[TBL] [Abstract][Full Text] [Related]
28. Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines.
Nielsen AL; Nørby PL; Pedersen FS; Jørgensen P
J Virol; 1996 Sep; 70(9):5893-901. PubMed ID: 8709209
[TBL] [Abstract][Full Text] [Related]
29. Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines.
Plumb M; Fulton R; Breimer L; Stewart M; Willison K; Neil JC
J Virol; 1991 Apr; 65(4):1991-9. PubMed ID: 1848314
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.
Lawrenz-Smith SC; Massey AC; Innes DJ; Thomas CY
J Virol; 1994 Aug; 68(8):5174-83. PubMed ID: 8035516
[TBL] [Abstract][Full Text] [Related]
31. Triple basepair changes within and adjacent to the conserved YY1 motif upstream of the U3 enhancer repeats of SL3-3 murine leukemia virus cause a small but significant shortening of latency of T-lymphoma induction.
Ma SL; Lovmand J; Sørensen AB; Luz A; Schmidt J; Pedersen FS
Virology; 2003 Sep; 313(2):638-44. PubMed ID: 12954229
[TBL] [Abstract][Full Text] [Related]
32. Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.
Massey AC; Lawrenz-Smith SC; Innes DJ; Thomas CY
J Virol; 1994 Jun; 68(6):3773-83. PubMed ID: 8189515
[TBL] [Abstract][Full Text] [Related]
33. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.
LoSardo JE; Cupelli LA; Short MK; Berman JW; Lenz J
J Virol; 1989 Mar; 63(3):1087-94. PubMed ID: 2644446
[TBL] [Abstract][Full Text] [Related]
34. Relative importance of elements within the SL3-3 virus enhancer for T-cell specificity.
LoSardo JE; Boral AL; Lenz J
J Virol; 1990 Apr; 64(4):1756-63. PubMed ID: 2157056
[TBL] [Abstract][Full Text] [Related]
35. Mutant analysis of protein interactions with a nuclear factor I binding site in the SL3-3 virus enhancer.
Nilsson P; Hallberg B; Thornell A; Grundström T
Nucleic Acids Res; 1989 Jun; 17(11):4061-75. PubMed ID: 2544855
[TBL] [Abstract][Full Text] [Related]
36. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
37. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
Speck NA; Renjifo B; Hopkins N
J Virol; 1990 Feb; 64(2):543-50. PubMed ID: 2104942
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of subspecies of polyomavirus and murine leukemia virus enhancer core binding protein, PEBP2, in various hematopoietic cells.
Satake M; Inuzuka M; Shigesada K; Oikawa T; Ito Y
Jpn J Cancer Res; 1992 Jul; 83(7):714-22. PubMed ID: 1325429
[TBL] [Abstract][Full Text] [Related]
39. Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.
Lund AH; Schmidt J; Luz A; Sørensen AB; Duch M; Pedersen FS
J Virol; 1999 Jul; 73(7):6117-22. PubMed ID: 10364369
[TBL] [Abstract][Full Text] [Related]
40. A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes.
Yoshimura FK; Diem K; Chen H; Tupper J
J Virol; 1993 Apr; 67(4):2298-304. PubMed ID: 8383242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
